These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6751521)

  • 1. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
    Huseby RA; Page RH
    Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression.
    Huseby RA
    Cancer Res; 1983 Nov; 43(11):5365-78. PubMed ID: 6616470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines.
    Sato B; Maeda Y; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
    Cancer Res; 1984 Oct; 44(10):4386-91. PubMed ID: 6467199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
    Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis.
    Kurland G; Christensen AK; Huseby RA
    Cancer Res; 1975 Jul; 35(7):1671-86. PubMed ID: 236824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA synthesis and DNA polymerase activity in Leydig cells of diethylstilbestrol-stimulated mouse testes.
    Spruance SL; Wilcox B; Richards OC; Foster DN; Huseby RA; Samuels LT
    Cancer Res; 1978 Feb; 38(2):424-30. PubMed ID: 620411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
    Juriansz RL; Huseby RA; Wilcox RB
    Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency.
    Huseby RA
    J Toxicol Environ Health Suppl; 1976; 1():177-92. PubMed ID: 11351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological studies on mouse testicular tumor. Humoral antibody response against testicular interstitial cell tumor in tumor-bearing mice (author's transl)].
    Osato K; Ikoma F
    Nihon Hinyokika Gakkai Zasshi; 1975 Oct; 66(10):683-8. PubMed ID: 1240545
    [No Abstract]   [Full Text] [Related]  

  • 11. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
    Korbelik M; Dougherty GJ
    Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse.
    Huseby RA
    Cancer Res; 1980 Apr; 40(4):1006-13. PubMed ID: 7357531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
    Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic cell therapy for a murine mammary carcinoma.
    Morecki S; Yacovlev E; Diab A; Slavin S
    Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.